Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jayne

Showing results (231-240 of 341) with videos related to

Pageof 35
Sort By:
Journal of the American Society of Nephrology : JASN|November 5, 2011
Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticlesYing Hong, Despina Eleftheriou, Abdullah A K Hussain, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 21, 2018
Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitisStephen P McAdoo, Nicholas Medjeral-Thomas, Seerapani Gopaluni, et al.
Pulmonary Circulation|December 6, 2011
Isolated large vessel pulmonary vasculitis as a cause of chronic obstruction of the pulmonary arteriesGuy Hagan, Deepa Gopalan, Colin Church, et al.
Arthritis and Rheumatism|June 7, 2013
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III studyEduardo F Mysler, Alberto J Spindler, Renato Guzman, et al.
Seminars in Arthritis and Rheumatism|July 18, 2021
Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020Kaitlin A Quinn, Sara Monti, Robin Christensen, et al.
Trials|August 2, 2020
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trialIng Ni Lu, Spoorthy Kulkarni, Marie Fisk, et al.
ACS Applied Materials & Interfaces|February 23, 2022
Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using <i>In Vitro</i> and <i>In Vivo</i> ModelsArindam Pramanik, Zexi Xu, Shazana H Shamsuddin, et al.
Annals of Internal Medicine|November 3, 2005
Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndromeRégis Sablé-Fourtassou, Pascal Cohen, Alfred Mahr, et al.
Trials|March 19, 2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trialMichael Walsh, Peter A Merkel, Chen Au Peh, et al.
BMJ Open|June 17, 2021
'Overnight, things changed. Suddenly, we were in it': a qualitative study exploring how surgical teams mitigated risks of COVID-19Daisy Elliott, Cynthia Ochieng, Marcus Jepson, et al.
Pageof 35

Showing results (231-240 of 341) with videos related to

Sort By:
Pageof 35
Journal of the American Society of Nephrology : JASN|November 5, 2011
Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticlesYing Hong, Despina Eleftheriou, Abdullah A K Hussain, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 21, 2018
Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitisStephen P McAdoo, Nicholas Medjeral-Thomas, Seerapani Gopaluni, et al.
Pulmonary Circulation|December 6, 2011
Isolated large vessel pulmonary vasculitis as a cause of chronic obstruction of the pulmonary arteriesGuy Hagan, Deepa Gopalan, Colin Church, et al.
Arthritis and Rheumatism|June 7, 2013
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III studyEduardo F Mysler, Alberto J Spindler, Renato Guzman, et al.
Seminars in Arthritis and Rheumatism|July 18, 2021
Developing a composite outcome tool to measure response to treatment in ANCA-associated vasculitis: A mixed methods study from OMERACT 2020Kaitlin A Quinn, Sara Monti, Robin Christensen, et al.
Trials|August 2, 2020
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trialIng Ni Lu, Spoorthy Kulkarni, Marie Fisk, et al.
ACS Applied Materials & Interfaces|February 23, 2022
Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using <i>In Vitro</i> and <i>In Vivo</i> ModelsArindam Pramanik, Zexi Xu, Shazana H Shamsuddin, et al.
Annals of Internal Medicine|November 3, 2005
Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndromeRégis Sablé-Fourtassou, Pascal Cohen, Alfred Mahr, et al.
Trials|March 19, 2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trialMichael Walsh, Peter A Merkel, Chen Au Peh, et al.
BMJ Open|June 17, 2021
'Overnight, things changed. Suddenly, we were in it': a qualitative study exploring how surgical teams mitigated risks of COVID-19Daisy Elliott, Cynthia Ochieng, Marcus Jepson, et al.
Pageof 35